Movement Alert｜10x Genomics, Inc. Falls 5.07% in Regular Trading, Major Shareholder Files Form 144 Signaling Planned Share Sale

Market Focus09-24

On September 24, 10x Genomics, Inc. declined 5.07% in regular trading, trading at approximately $76.55 per share with turnover of $105 million. The selloff was triggered by a recently disclosed Form 144 filing, indicating that a significant shareholder intends to sell company shares, raising concerns about near-term selling pressure.

The filing, dated September 22, reports the proposed sale of securities by a major insider. The timing of the disclosure is notable as the stock has recently rallied well above key analyst price targets — UBS set a $68 target on September 9, while RBC initiated coverage at $70 on September 1 — meaning the current share price sits meaningfully above both levels. This gap between market price and institutional valuations, combined with the insider sale signal, has amplified profit-taking sentiment among investors.

10x Genomics, Inc. is a life science technology company that develops and sells instruments, consumables, and software for analyzing biological systems. The company serves academic, government, biopharmaceutical, and biotechnology institutions globally.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1107471301?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-09-24 00:51","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1107471301","market":"us","top_or_hot":-1,"title":"Movement Alert｜10x Genomics, Inc. Falls 5.07% in Regular Trading, Major Shareholder Files Form 144 Signaling Planned Share Sale","media":"Market Focus","content":"<p><p>On September 24, 10x Genomics, Inc. declined 5.07% in regular trading, trading at approximately $76.55 per share with turnover of $105 million. The selloff was triggered by a recently disclosed Form 144 filing, indicating that a significant shareholder intends to sell company shares, raising concerns about near-term selling pressure.</p><p>The filing, dated September 22, reports the proposed sale of securities by a major insider. The timing of the disclosure is notable as the stock has recently rallied well above key analyst price targets — UBS set a $68 target on September 9, while RBC initiated coverage at $70 on September 1 — meaning the current share price sits meaningfully above both levels. This gap between market price and institutional valuations, combined with the insider sale signal, has amplified profit-taking sentiment among investors.</p><p>10x Genomics, Inc. is a life science technology company that develops and sells instruments, consumables, and software for analyzing biological systems. The company serves academic, government, biopharmaceutical, and biotechnology institutions globally.</p><p>(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)</p></p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Movement Alert｜10x Genomics, Inc. Falls 5.07% in Regular Trading, Major Shareholder Files Form 144 Signaling Planned Share Sale</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nMovement Alert｜10x Genomics, Inc. Falls 5.07% in Regular Trading, Major Shareholder Files Form 144 Signaling Planned Share Sale\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1054767329\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/51943b2858f75e05ca2ebb144b4e626a);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Market Focus </p>\n<p class=\"h-time\">2026-09-24 00:51</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p><p>On September 24, 10x Genomics, Inc. declined 5.07% in regular trading, trading at approximately $76.55 per share with turnover of $105 million. The selloff was triggered by a recently disclosed Form 144 filing, indicating that a significant shareholder intends to sell company shares, raising concerns about near-term selling pressure.</p><p>The filing, dated September 22, reports the proposed sale of securities by a major insider. The timing of the disclosure is notable as the stock has recently rallied well above key analyst price targets — UBS set a $68 target on September 9, while RBC initiated coverage at $70 on September 1 — meaning the current share price sits meaningfully above both levels. This gap between market price and institutional valuations, combined with the insider sale signal, has amplified profit-taking sentiment among investors.</p><p>10x Genomics, Inc. is a life science technology company that develops and sells instruments, consumables, and software for analyzing biological systems. The company serves academic, government, biopharmaceutical, and biotechnology institutions globally.</p><p>(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)</p></p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"TXG","symbol_name":"10x Genomics, Inc.","start_time":0,"source_url":"","article_id":"1107471301","we_media_id":"1054767329","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1107471301","pubTimestamp":1790182299,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Market Focus","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1054767329","head_image":"https://static.tigerbbs.com/51943b2858f75e05ca2ebb144b4e626a"},"summary":"On September 24, 10x Genomics, Inc. declined 5.07% in regular trading, trading at approximately $76.55 per share with turnover of $105 million. The selloff was triggered by a recently disclosed Form...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"TXG":"10x Genomics, Inc."},"translate_title":"走势警报|10x Genomics, Inc. 常规交易中下跌 5.07%，主要股东提交 144 表格，表明计划出售股票","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"TXG":1},"content_text":"On September 24, 10x Genomics, Inc. declined 5.07% in regular trading, trading at approximately $76.55 per share with turnover of $105 million. The selloff was triggered by a recently disclosed Form 144 filing, indicating that a significant shareholder intends to sell company shares, raising concerns about near-term selling pressure.The filing, dated September 22, reports the proposed sale of securities by a major insider. The timing of the disclosure is notable as the stock has recently rallied well above key analyst price targets — UBS set a $68 target on September 9, while RBC initiated coverage at $70 on September 1 — meaning the current share price sits meaningfully above both levels. This gap between market price and institutional valuations, combined with the insider sale signal, has amplified profit-taking sentiment among investors.10x Genomics, Inc. is a life science technology company that develops and sells instruments, consumables, and software for analyzing biological systems. The company serves academic, government, biopharmaceutical, and biotechnology institutions globally.(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"-1","news_tag":"shareholding","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.50.1","shortVersion":"4.50.1","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1107471301","isCrawlerRequest":true}